-
FDA approves first subcutaneous drug for EGFR-mutated non-small cell lung cancer
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered... Read more -
Iron-snatching compounds found to be effective against parasitic flatworm
A series of compounds that deprive iron essential for a parasitic worm could provide effective new agents for blocking parasite... Read more -
Novo Nordisk says US approves first GLP-1 pill for weight loss
Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity... Read more -
Cannabis products with more THC can slightly reduce pain but cause more side effects
A new systematic evidence review finds that cannabis products that carry relatively high levels of the psychoactive compound tetrahydrocannabinol, commonly... Read more -
Antiviral trial ties valacyclovir to faster cognitive decline
New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional US centers, report greater cognitive... Read more -
Natural protein drug may slow neuron death linked to Alzheimer's disease
Scientists at the University of Colorado Anschutz have discovered that while brain neuron changes, including cell loss, may begin in... Read more -
Combined oral contraceptive use among people with migraine with aura persists, despite cautions
Current medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of... Read more -
Researchers seek better, safer alternatives to current opioid drugs
Researchers at USF Health are making dramatic strides in understanding how new opioid compounds work inside the body to provide... Read more -
Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?
Popular new anti-obesity medications can help people lose 10% to 20% of their body weight, yet a new study indicates... Read more -
High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds
A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This severe form... Read more -
Antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce... Read more -
FDA approves Waskyra for Wiskott-Aldrich syndrome
The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment... Read more -
Little awareness of medical and psychological complexities of steroid cream withdrawal
There is little awareness, particularly among clinicians, of the medical and psychological complexities of "topical steroid withdrawal"—the body's adverse response... Read more -
My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs
Even when Americans have health insurance, they can have a hard time affording the drugs they've been prescribed.... Read more -
Osteoporosis medicines might offer help for chronic pain after injury or surgery
A systematic review and meta-analysis has found that bisphosphonates—medicines commonly used to treat osteoporosis—may offer short-term pain relief for people... Read more
